CollPlant Biotechnologies Ltd (CLGN) › Operating IncomeCollPlant Biotechnologies Ltd (CLGN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$4.25M2019: -$7.63M2020: -$5.60M2021: $65.0K2022: -$17.10M2023: -$7.51M2024: -$17.25M2025: -$11.48M-$11.48M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$11.48M+33.4%2024-$17.25M-129.6%2023-$7.51M+56.1%2022-$17.10M-26403.1%2021$65.0K+101.2%2020-$5.60M+26.6%2019-$7.63M-79.8%2018-$4.25M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share